Select Page

Forty51 Ventures

FORTY51 Ventures is a biotech venture creator investing in European early-stage biotech companies with a clear clinical path, as first institutional investor.
Funding Stage: Pre-Seed / Seed
Investor type: VC Firm
Investment Areas: Biotechnology research, Entrepreneur, Investing, Therapeutic
Country: Switzerland

Categories

Details about how we process your information are available in our Privacy Policy.